Safety of Imatinib Mesylate in a Multicenter Expanded Access Program in Adult Patients with Gastrointestinal Stromal Tumors in the Adjuvant Setting
FI: 1,483
Type: Article
Collaboration
Year: 2019
Writers
Reichardt, P; Schlemmer, M; Perez, JRD; Papai, Z; Prausova, J; Melichar, B; Fumagalli, E; Baron, C; Bauer, S; Pustowka, A; Crippa, S; Castellana, R; Wanting, C; Le Cesne, A.
Magazine
Title: ONCOLOGY RESEARCH AND TREATMENT
Quartile
- Q4